New Asthma Project Funding from NHLBI

August 20, 2014

Vadim Gurvich, ITDD Chemical Process Development Core Director, received a National Heart, Lung, and Blood Institute Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II) award for his project, "Preclinical Development of Myosolvins, a New Class of Medicine for Asthma."

Categories: Health Sciences News